Intravitreal Bevacizumab Alone Versus Combined Bevacizumab and Macular Grid Laser Photocoagulation in Diffuse Diabetic Macular Oedema
Introduction: Diabetes Mellitus (DM) is a common disease with multiple systemic complications. Diabetic macular oedema is the main threat to vision in patients with diabetic retinopathy, which results from the increased permeability of the inner and outer blood-retinal barrier. Macular argon las...
Main Authors: | Fawaz Al Sarireh, Hamzeh Mohammad Alrawashdeh, Khalid Al Zubi, Khalil Al Salem |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
JCDR Research and Publications Private Limited
2020-11-01
|
Colecção: | Journal of Clinical and Diagnostic Research |
Assuntos: | |
Acesso em linha: | https://jcdr.net/articles/PDF/14179/45742_CE[Ra1]_F(SL)_PF1(AG_KM)_PFA_PB(AG_KM)_PN(SL).pdf |
Registos relacionados
-
Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
Por: Kartasasmita A, et al.
Publicado em: (2019-09-01) -
Intravitreal bevacizumab plus macular laser photocoagulation for treatment of diabetic macular edema
Por: Ahmed H Mohamed
Publicado em: (2016-01-01) -
Changes in Macular Oedema by Optical Coherence Tomography in Patients Receiving Intravitreal Bevacizumab: A Retrospective Observational Hospital Based Study
Por: Ajit K Joshi, et al.
Publicado em: (2020-06-01) -
Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema
Por: Gopal K Das, et al.
Publicado em: (2018-01-01) -
Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study
Por: Wei Zhang, et al.
Publicado em: (2021-04-01)